Annual Report
Filed: 2026-04-14
Key Insights
- Accustem Sciences Inc. (ACUT) reported financial results for the fiscal year 2025, with increases in common stock, additional paid-in capital, and related party subscription receivables compared to the prior year.
- The company renewed its directors and officers liability insurance agreement in 2025 and 2024, indicating management's focus on risk mitigation and corporate governance.
- ACUT has granted employee stock options and warrants during the reported periods, which could dilute existing shareholders if exercised.